MICHIELI, Paolo
MICHIELI, Paolo
ONCOLOGIA
A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met
2008-01-01 Basilico C; Arnesano A; Galluzzo M; Comoglio PM; Michieli P
A Mesenchymal-epithelial transition factor-Agonistic Antibody Accelerates Cirrhotic Liver Regeneration and Improves Mouse Survival Following Partial Hepatectomy
2021-01-01 Ma K.; Que W.; Hu X.; Guo W.-Z.; Gu E.-L.; Zhong L.; Morello V.; Cazzanti M.; Michieli P.; Takahara T.; Li X.-K.
A novel dual specificity phosphatase induced by serum stimulation and heat shock.
1994-01-01 Ishibashi T;Bottaro DP;Michieli P;Kelley CA;Aaronson SA
A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1.
1994-01-01 Chedid M;Michieli P;Lengel C;Huppi K;Givol D
ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancer.
2014-01-01 Van Schaeybroeck S;Kalimutho M;Dunne PD;Carson R;Allen W;Jithesh PV;Redmond KL;Sasazuki T;Shirasawa S;Blayney J;Michieli P;Fenning C;Lenz HJ;Lawler M;Longley DB;Johnston PG
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity.
2002-01-01 MICHIELI P; CAVASSA S; BASILICO C; DE LUCA A; MAZZONE M; ASTI C; CHIUSAROLI R; GUGLIELMI M; BOSSU' P; COLOTTA F; CASELLI G; PM COMOGLIO
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice
2004-01-01 MAZZONE M; BASILICO C; CAVASSA S; PENNACCHIETTI S; RISIO M; NALDINI L; PM COMOGLIO; MICHIELI P
Anti C-met Antibodies - granted patent (Canada)
2019-01-01 Hultberg Anna; Saunders Michael; De Haard Johannes; Festjens Els; De Jonge Natalie; Michieli Paolo; Basilico Cristina; Dreier Torsten
ANTI-MET ANTIBODIES AND USES THEREOF
2017-01-01 Paolo Michieli
Antibody Fragments, Compositions And Uses Thereof - granted patent (USA)
2019-01-01 Elisa Vigna; Paolo Michieli; Paolo Maria Comoglio
Correction: Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from Apoptosis
2019-01-01 Cassano, Marco; Biressi, Stefano; Finan, Amanda; Benedetti, Laura; Omes, Claudia; Boratto, Renata; Martin, Frank; Allegretti, Marcello; Broccoli, Vania; Cusella De Angelis, Gabriella; Comoglio, Paolo M; Basilico, Cristina; Torrente, Yvan; Michieli, Paolo; Cossu, Giulio; Sampaolesi, Maurilio
Depleting MET-expressing tumor cells by ADCC provides a therapeutic advantage over inhibiting HGF/MET signaling
2015-01-01 Hultberg, Anna; Morello, Virginia; Huyghe, Leander; De Jonge, Natalie*; Blanchetot, Christophe; Hanssens, Valérie; De Boeck, Gitte; Silence, Karen; Festjens, Els; Heukers, Raimond; Roux, Benjamin; Lamballe, Fabienne; Ginestier, Christophe; Charafe-Jauffret, Emmanuelle; Maina, Flavio; Brouckaert, Peter; Saunders, Michael; Thibault, Alain; Dreier, Torsten; De Haard, Hans; Michieli, Paolo
Different point mutations in the met oncogene elicit distinct biological properties.
2000-01-01 GIORDANO S; MAFFÈ A; WILLIAMS T A; ARTIGIANI S; GUAL P; BARDELLI A; BASILICO C; MICHIELI P; P. COMOGLIO
Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy
2016-01-01 Godar, Marie; Morello, Virginia; Sadi, Ava; Hultberg, Anna; De Jonge, Natalie; Basilico, Cristina; Hanssens, Valérie; Saunders, Michael; Lambrecht, Bart N.; El Khattabi, Mohamed; De Haard, Hans; Michieli, Paolo; Blanchetot, Christophe*
Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody
2016-01-01 Cignetto, Simona; Modica, Chiara; Chiriaco, Cristina; Fontani, Lara; Milla, Paola; Michieli, Paolo; Comoglio, Paolo M.; Vigna, Elisa
Expression and Functional Regulation of Myoglobin in Epithelial Cancers
2009-01-01 Flonta SE; Arena S; Pisacane A; Michieli P; Bardelli A
Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
1996-01-01 Li W;Michieli P;Alimandi M;Lorenzi MV;Wu Y;Wang LH;Heidaran MA;Pierce JH
Four individually druggable MET hotspots mediate HGF-driven tumor progression.
2014-01-01 Basilico C;Hultberg A;Blanchetot C;de Jonge N;Festjens E;Hanssens V;Osepa SI;De Boeck G;Mira A;Cazzanti M;Morello V;Dreier T;Saunders M;de Haard H;Michieli P
Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.
1993-01-01 Donghi R;Longoni A;Pilotti S;Michieli P;Della Porta G;Pierotti MA
HGF-MET AGONIST FOR USE IN THE TREATMENT OF CANCER AND COLORECTAL FIBROSIS
2019-01-01 Paolo Michieli
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met | 2008 | Basilico C; Arnesano A; Galluzzo M; Comoglio PM; Michieli P | |
| A Mesenchymal-epithelial transition factor-Agonistic Antibody Accelerates Cirrhotic Liver Regeneration and Improves Mouse Survival Following Partial Hepatectomy | 2021 | Ma K.; Que W.; Hu X.; Guo W.-Z.; Gu E.-L.; Zhong L.; Morello V.; Cazzanti M.; Michieli P.; Takahara T.; Li X.-K. | |
| A novel dual specificity phosphatase induced by serum stimulation and heat shock. | 1994 | Ishibashi T;Bottaro DP;Michieli P;Kelley CA;Aaronson SA | |
| A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. | 1994 | Chedid M;Michieli P;Lengel C;Huppi K;Givol D | |
| ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancer. | 2014 | Van Schaeybroeck S;Kalimutho M;Dunne PD;Carson R;Allen W;Jithesh PV;Redmond KL;Sasazuki T;Shirasawa S;Blayney J;Michieli P;Fenning C;Lenz HJ;Lawler M;Longley DB;Johnston PG | |
| An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity. | 2002 | MICHIELI P; CAVASSA S; BASILICO C; DE LUCA A; MAZZONE M; ASTI C; CHIUSAROLI R; GUGLIELMI M; BOSSU' P; COLOTTA F; CASELLI G; PM COMOGLIO | |
| An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice | 2004 | MAZZONE M; BASILICO C; CAVASSA S; PENNACCHIETTI S; RISIO M; NALDINI L; PM COMOGLIO; MICHIELI P | |
| Anti C-met Antibodies - granted patent (Canada) | 2019 | Hultberg Anna; Saunders Michael; De Haard Johannes; Festjens Els; De Jonge Natalie; Michieli Paolo; Basilico Cristina; Dreier Torsten | |
| ANTI-MET ANTIBODIES AND USES THEREOF | 2017 | Paolo Michieli | |
| Antibody Fragments, Compositions And Uses Thereof - granted patent (USA) | 2019 | Elisa Vigna; Paolo Michieli; Paolo Maria Comoglio | |
| Correction: Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from Apoptosis | 2019 | Cassano, Marco; Biressi, Stefano; Finan, Amanda; Benedetti, Laura; Omes, Claudia; Boratto, Renata; Martin, Frank; Allegretti, Marcello; Broccoli, Vania; Cusella De Angelis, Gabriella; Comoglio, Paolo M; Basilico, Cristina; Torrente, Yvan; Michieli, Paolo; Cossu, Giulio; Sampaolesi, Maurilio | |
| Depleting MET-expressing tumor cells by ADCC provides a therapeutic advantage over inhibiting HGF/MET signaling | 2015 | Hultberg, Anna; Morello, Virginia; Huyghe, Leander; De Jonge, Natalie*; Blanchetot, Christophe; Hanssens, Valérie; De Boeck, Gitte; Silence, Karen; Festjens, Els; Heukers, Raimond; Roux, Benjamin; Lamballe, Fabienne; Ginestier, Christophe; Charafe-Jauffret, Emmanuelle; Maina, Flavio; Brouckaert, Peter; Saunders, Michael; Thibault, Alain; Dreier, Torsten; De Haard, Hans; Michieli, Paolo | |
| Different point mutations in the met oncogene elicit distinct biological properties. | 2000 | GIORDANO S; MAFFÈ A; WILLIAMS T A; ARTIGIANI S; GUAL P; BARDELLI A; BASILICO C; MICHIELI P; P. COMOGLIO | |
| Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy | 2016 | Godar, Marie; Morello, Virginia; Sadi, Ava; Hultberg, Anna; De Jonge, Natalie; Basilico, Cristina; Hanssens, Valérie; Saunders, Michael; Lambrecht, Bart N.; El Khattabi, Mohamed; De Haard, Hans; Michieli, Paolo; Blanchetot, Christophe* | |
| Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody | 2016 | Cignetto, Simona; Modica, Chiara; Chiriaco, Cristina; Fontani, Lara; Milla, Paola; Michieli, Paolo; Comoglio, Paolo M.; Vigna, Elisa | |
| Expression and Functional Regulation of Myoglobin in Epithelial Cancers | 2009 | Flonta SE; Arena S; Pisacane A; Michieli P; Bardelli A | |
| Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells. | 1996 | Li W;Michieli P;Alimandi M;Lorenzi MV;Wu Y;Wang LH;Heidaran MA;Pierce JH | |
| Four individually druggable MET hotspots mediate HGF-driven tumor progression. | 2014 | Basilico C;Hultberg A;Blanchetot C;de Jonge N;Festjens E;Hanssens V;Osepa SI;De Boeck G;Mira A;Cazzanti M;Morello V;Dreier T;Saunders M;de Haard H;Michieli P | |
| Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. | 1993 | Donghi R;Longoni A;Pilotti S;Michieli P;Della Porta G;Pierotti MA | |
| HGF-MET AGONIST FOR USE IN THE TREATMENT OF CANCER AND COLORECTAL FIBROSIS | 2019 | Paolo Michieli |